Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000362907 http://scihub22266oqcxt.onion/10.1159/000362907 C4645571!4645571!26674591     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gastrointest+Tumors 2014 ; 1 (2): 105-13 Nephropedia Template TP {{tp|p=26674591|t=2014. Esophageal Cancer: Current Options for Therapeutic Management |pdf=|usr=}}{{26674591}} gab.com Text Esophageal Cancer: Current Options for Therapeutic Management JO: Gastrointest Tumors http://www.kidney.de/pget.php?&tw=1&pmid=26674591 #FOAvip Background: Esophageal cancer (EC) is the eighth most common cancer worldwide. A worldwide-established consensus on therapeutic pathways for EC is still missing. Debate exists on whether neoadjuvant and adjuvant treatment regimens improve the prognosis and which surgical approach reaches objective benefits. Summary: This article discusses the appropriate option of the current different curative treatments in patients with EC, including surgical treatment and adjuvant therapy. Key Message: To maximize survival and quality of life and also decrease postoperative complications, the present recommended therapeutic management of EC should be individualized multidisciplinary team approaches according to patients' staging and physiologic reserve. Practical Implications: The aim of this article is to provide a decision support and also a discussion based on clinical therapeutic strategy in order to characterize the beneficial approach which reaches an optimal balance between radical resection, postoperative outcome and long-term survival of EC. Twit Text FOAVip Esophageal Cancer: Current Options for Therapeutic Management ????Gastrointest Tumors http://www.kidney.de/pget.php?&tw=1&pmid=26674591 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26674591 #FOAvip English Wikipedia <ref>{{Cite pmid|26674591}}</ref> Esophageal Cancer: Current Options for Therapeutic Management #MMPMID26674591 Sun L; Zhang H; Wu K Gastrointest Tumors 2014[Jun]; 1 (2): 105-13 PMID26674591show ga Background: Esophageal cancer (EC) is the eighth most common cancer worldwide. A worldwide-established consensus on therapeutic pathways for EC is still missing. Debate exists on whether neoadjuvant and adjuvant treatment regimens improve the prognosis and which surgical approach reaches objective benefits. Summary: This article discusses the appropriate option of the current different curative treatments in patients with EC, including surgical treatment and adjuvant therapy. Key Message: To maximize survival and quality of life and also decrease postoperative complications, the present recommended therapeutic management of EC should be individualized multidisciplinary team approaches according to patients' staging and physiologic reserve. Practical Implications: The aim of this article is to provide a decision support and also a discussion based on clinical therapeutic strategy in order to characterize the beneficial approach which reaches an optimal balance between radical resection, postoperative outcome and long-term survival of EC. äEsophageal Cancer: Current Options for Therapeutic Management (epmc).pdf DeepDyve Pubget Overpricing